Bora Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Bora Pharmaceuticals has a total shareholder equity of NT$13.9B and total debt of NT$17.9B, which brings its debt-to-equity ratio to 128.3%. Its total assets and total liabilities are NT$43.6B and NT$29.6B respectively. Bora Pharmaceuticals's EBIT is NT$4.0B making its interest coverage ratio 13.1. It has cash and short-term investments of NT$6.5B.
Key information
128.3%
Debt to equity ratio
NT$17.87b
Debt
| Interest coverage ratio | 13.1x |
| Cash | NT$6.48b |
| Equity | NT$13.93b |
| Total liabilities | NT$29.64b |
| Total assets | NT$43.57b |
Recent financial health updates
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19Recent updates
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Financial Position Analysis
Short Term Liabilities: 6472's short term assets (NT$23.8B) exceed its short term liabilities (NT$13.1B).
Long Term Liabilities: 6472's short term assets (NT$23.8B) exceed its long term liabilities (NT$16.5B).
Debt to Equity History and Analysis
Debt Level: 6472's net debt to equity ratio (81.7%) is considered high.
Reducing Debt: 6472's debt to equity ratio has increased from 32% to 128.3% over the past 5 years.
Debt Coverage: 6472's debt is not well covered by operating cash flow (13.2%).
Interest Coverage: 6472's interest payments on its debt are well covered by EBIT (13.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 07:24 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bora Pharmaceuticals Co., LTD. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jianzheng Wu | Capital Securities Corporation |
| null null | Capital Securities Corporation |
| Hsuan Chen | KGI Securities Co. Ltd. |